28
Participants
Start Date
September 15, 2015
Primary Completion Date
February 28, 2018
Study Completion Date
May 24, 2019
Azacitidine
Hopital Universitaire des Enfants, Brussels
St. Anna Kinderkrebsforschung, CHILDREN'S CANCER RESEARCH INSTITUTE, Vienna
Universitatsklinikum, Jena
Universitäts-Kinderklinik, Zurich
Hospital Sant Joan de Deu, Barcelona
University Hospital Ghent, Ghent
Regina Margherita Children's Hospital, Torino
Hopital d'Enfants de la Timone, Marseille
Charite Berlin, Berlin
IRCCS Gaslini Hospital, Genova Quarto
University of Hamburg, Hamburg
Azienda Ospedaliera San Gerardo, Monza
Universitatsklinikum Schleswig-Holstein, Kiel
IRCCS Policlinico San Matteo, Pavia
Hospital Infantil Universitario Nino Jesus, Madrid
Hospital Universitario Virgen de La Arrixaca, Murcia
Medizinische Hochschule Hannover, Hanover
General Hospital, Padua
Policlinico Sant'Orsola-Malpighi, Bologna
Hematology, Oncology and clinical immunology / Heinrich-Heine-University, Düsseldorf
Universitatsklinikum Essen, Essen
Universitatsklinik Munster, Münster
Klinikum der Johann Wolfgang Goethe-Universität Frankfurt/Main, Frankfurt am Main
Centre Hospitalier Universitaire Lyon, Lyon
Universitatsklinikum, Tübingen
Hopital Robert Debre, Paris
Universitatsklinik, Freiburg im Breisgau
Klinikum der Universitaet Muenchen, München
Klinikum Augsburg, Augsburg
Krankenhaus Barmherzige Bruder Regensburg, Regensburg
University Hospital Motol, Prague
Rigshospitalet, Copenhagen
Universitaetsklinikum Carl Gustav Carus, Dresden
Our Lady's Hospital for Sick Children, Dublin
Ospedale Bambin Gesu, Roma
Erasmus University Medical Center, Rotterdam
Queen Silvia Childrens Hospital, Gothenburg
Karolinska University Hospital, Stockholm
Royal Manchester Children's Hospital, Manchester
Lead Sponsor
Celgene
INDUSTRY